title: Inherited hypercoagulable states: questions and controversies.
abstract: Inherited hypercoagulable states such as protein C, protein S, and antithrombin III deficiencies account for 15% to 20% of recurrent thromboembolic episodes. A common risk profile is associated with these disorders and guides the use of laboratory screening. The use of anticoagulants in inherited hypercoagulable states varies with a patient's personal and familial history of thrombosis. Special consideration is given to the need for anticoagulants perioperatively and during pregnancy.
authors.forename: S
authors.initials: S
authors.lastname: Schenk
authors.forename: S H
authors.initials: SH
authors.lastname: Goodnight
mesh_terms: D001778:Blood Coagulation Disorders / Q000150:complications / Q000151:congenital*; D006801:Humans; D009722:Nurse Practitioners; D013923:Thromboembolism / Q000188:drug therapy* / Q000209:etiology / Q000451:nursing